Home

Podcasts

 
Lancet Podcasts. Gruesome tales
May 18 2012, The Lancet

 A gruesome tale of human flesh in pills, a drug to prevent HIV, and dignified death in Argentina.   Plus news from this weeks' The Lancet Oncology and The Lancet's World Report desk. Mario Christodoulou and Dara Mohammadi report
Gay and Bisexual Health in the UK, and the Detection of Mad Cow Disease in the USA
May 7 2012, The Lancet

This week's Lancet News looks at a mystery disease in Vietnam, gay and bisexual health in the UK, and the detection of mad cow disease in the USA. And, as always, we give you a rundown of this week's news from The Lancet Oncology
Antibiotics in Farm Animals
April 24 2012, The Lancet

 Mario Christodoulou and Dara Mohammadi discuss antibiotics in farm animals, repeal of the death penalty in Connecticut, and cut-price rotavirus vaccines low-income countries
Highlights from the April 14 issue, and introducing The Lancet News podcast
April 16 2012, The Lancet

 
Physicians for Human Rights
April 3 2012, The Lancet

 Discussion with Donna McKay, Physicians for Human Rights' new Executive Director.
How deaf people are often alienated from accessing the UK health-care system
March 19 2012, The Lancet

 Andrew Alexander discusses how deaf people are often alienated from accessing the UK health-care system.
Stem cells and regenerative medicine
March 9 2012, The Lancet

 Paolo Macchiarini discusses stem cells and regenerative medicine, linked to a Stem Cells Series.   10:15 mins
New Position Statement Released for Exercise in CHF Patients
May 4 2010, Sunalie Silva, Cardiology News

Moderate aerobic activity combined with resistance and flexibility training help to improve clinical and functional outcomes, and may even reduce mortality and hospitalisation, for stable chronic heart failure patients according to the position statement on exercise training and chronic heart failure released by Exercise and Sport Science Australia.

Click here for podcast
Castrate-Resistant Prostate Cancer Cells Respond to Oestrogen, Study Finds
March 30 2010, Carolyn Ng, Clinical Endocrinology News

Professor Gail Risbridger discusses the potential of oestrogen to treat castrate-resistant prostate cancer cells. Monash University researchers recently identified that activation of oestrogen receptor-ß can result in cell death. In the study, published in Proceedings of the National Academy of Sciences, Professor Risbridger and colleagues demonstrated the beneficial effects of an oestrogen receptor agonist in treating both benign prostatic hyperplasia (BPH) and prostate cancer (2010;107:3123–8).

Click here for podcast
Listen to The Lancet Neurology: BENEFIT study for MS
November 1 2009

Discussion of the BENEFIT study for MS and the role of elderly people in neurological research. (mp3, 7:38 mins, 4.76Mb)

Click here for podcast